Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
ER positive
Cancer:
Uterine Leiomyosarcoma
Drug:
megestrol
(
Progesterone receptor agonist
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Uterine sarcoma: Systemic therapy for uterine sarcoma…Other recommended regimens…Megestrol acetate (category 2B for ER/PR-positive uLMS)
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.